Mortality, recurrence, and hospital course of patients with systemic sclerosis-related acute intestinal pseudo-obstruction

Christopher Mecoli, Shivani Purohit, Nora Sandorfi, Chris T. Derk

Research output: Contribution to journalArticle

Abstract

Objective. Acute intestinal pseudo-obstruction is a rare gastrointestinal manifestation of systemic sclerosis (SSc) with few data existing as to its demographics, clinical course, outcomes, and mortality. Methods. We undertook a case-control study to describe 64 cases in 37 unique patients, of whom 70% had spontaneous resolution with conservative measures of intravenous hydration and bowel rest, 9% underwent surgical resection, and 25% required prolonged total parenteral nutrition (TPN). Results. Hospital course was for a mean of 12 ± 12.5 days and there was a 16% patient mortality in our population. In a subgroup analysis, patients who had recurrent episodes of pseudo-obstruction were less likely to have esophageal involvement from SSc, and more likely to need prolonged TPN. Mortality tended to be higher in male patients and patients who did not have SSc-related esophageal involvement, and also in patients who had low hemoglobin and serum albumin at presentation. The need for a nasogastric tube for decompression and a surgical intervention correlated with a more prolonged hospital stay. Conclusion. To the best of our knowledge, ours is the largest study looking at this rare manifestation of SSc.

Original languageEnglish (US)
Pages (from-to)2049-2054
Number of pages6
JournalJournal of Rheumatology
Volume41
Issue number10
DOIs
StatePublished - Oct 1 2014
Externally publishedYes

Keywords

  • Clinical
  • Gastrointestinal
  • Intestinal
  • Obstruction
  • Scleroderma
  • Systemic sclerosis

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'Mortality, recurrence, and hospital course of patients with systemic sclerosis-related acute intestinal pseudo-obstruction'. Together they form a unique fingerprint.

  • Cite this